Table 2. Univariate and multivariate average hazard rate ratios of the investigated candidate biomarkers.
| univariate | multivariate | |||||
|---|---|---|---|---|---|---|
| Biomarker | HRRav | P (HRR < 1) | P (HRR > 1) | HRRav | P (HRR < 1) | P (HRR > 1) |
| EGFR [31] | 1.47 | .03* | 1.54 | .02* | ||
| PI3K | 0.88 | .20 | 0.80 | .20 | ||
| AURKA [32] | 1.57 | .02* | 1.66 | .02* | ||
| Ki-67 | 1.15 | .21 | 1.17 | .20 | ||
| TK1 | 1.22 | .26 | 1.31 | .23 | ||
| KCNQ1 | 0.81 | .09 | 0.81 | .09 | ||
| IGF2 | 0.97 | .39 | 0.96 | .37 | ||
| VEGFA [33] | 1.48 | .02* | 1.50 | .02* | ||
| PDGFR β | 1.13 | .29 | 1.10 | .35 | ||
| CEA | 0.68 | .06 | 0.63 | .05 | ||
| MMP9 | 1.29 | .08 | 1.34 | .07 | ||
| CXCR4 | 0.94 | .33 | 0.91 | .25 | ||
| CXCL12 | 0.90 | .23 | 0.93 | .31 | ||
| MLH1 | 1.16 | .23 | 1.17 | .21 | ||
| MSH6 | 0.81 | .11 | 0.82 | .13 | ||
| PTGS2 [31] | 1.63 | < .01* | 1.59 | .01* | ||
| SLC2A1 [33] | 0.67 | < .01* | 0.65 | < .01* | ||
| HIF1α [33] | 0.80 | .06 | 0.77 | .06 | ||
HRRav: average hazard rate ratio; P (HRR < 1): proportion of HRRs with HRR < 1; P (HRR > 1): proportion of HRRs with HRR > 1
P (HRR < 1) or P(HRR > 1) < .05